Norway

Country

Neuraxpharm Expands Into The Nordics With New Leader From Viatris

 
• By 

In line with its plan to expand into the Nordics, CNS specialist Neuraxpharm has established a new business unit in Stockholm and has recruited Viatris’ Magnus Wassén to lead it as general manager. The company is expecting Neuraxpharm Sweden to provide an immediate sales platform for Buccolam. 

Navamedic Benefits From Eroxon Launch In Nordics

 
• By 

OTC erectile dysfunction treatment Eroxon has made it to the Nordics through local distributor Navamedic, which has reported strong consumer uptake.

People On The Move: Appointments At Perrigo, European Commission, EFSA

 
• By 

A round-up of the latest appointments in Europe's health and wellness industries: Perrigo makes management changes; European Commission president re-elected; EFSA appoints new members to scientific panels.

Another Funding Win For Chiesi In Europe As Scotland OKs Elfabrio

 

Scotland’s health technology assessment body has agreed to reimburse Chiesi’s Elfabrio for Fabry disease, mirroring the decision from several other European countries – however, France turned down the rare disease drug, while Germany questioned its benefit.

Nordic HTA Initiative Offers ‘Practice Ground’ For Worrisome EU-Level Joint Clinical Assessment

 

Industry shoulders some blame for growing unease about joint clinical assessments after its failure to participate in pilots.

Pharma Dubs EU HTA Proposal ‘Unworkable,’ But Patient Groups Support The Plan

 

Pharmaceutical companies, NGOs, and patient organizations were among the 129 respondents to the European Commission’s consultation on its draft implementing act for joint clinical assessments – but opinions on the proposal were divided.

Norway's Orkla Prioritizes Seeing Off Private-Label Consumer Health Challenge

 
• By 

Alongside addressing the threat posed by private-label, Orkla Health CEO Isabelle Ducellier will over the coming three years focus on building global brands and simplifying the value chain to improve efficiency and extract synergies.

Fresenius Divests Norwegian Plant To Prange

 
• By 

Fresenius Kabi has completed the divestment of a manufacturing plant in Halden, Norway, to Prange Group.

Global Pharma Guidance Tracker – February 2024

 
• By 

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Global Pharma Guidance Tracker – January 2024

 
• By 

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

People On The Move: Appointments At Cooper, Orkla, TheOTCLab, Dr. Pfleger

 
• By 

A round-up of the latest appointments in Europe's consumer health market: Cooper Consumer Health names Spain & Portugal head; Orkla Health adds to board; TheOTCLab appoints first Germany manager; Dr. Pfleger hires digital specialist.

Sandoz Reveals European Natalizumab Launch Amid GLP-1 Ambitions

 
• By 

Sandoz arrived in California for its first J.P. Morgan Annual Healthcare Conference as an independent company. As well as revealing its first natalizumab biosimilar launch, the firm spoke at length about how it will look to capitalize on the growing GLP-1 market in the years ahead.

Sanofi Secures First EU Market Approval for OTC Cialis

 
• By 

Following an application through the decentralised procedure, Ireland is the first EU member state to approve Sanofi's Cialis (tadalafil) for non-prescription sale. An OTC version of the blockbuster erectile dysfunction treatment has also been given the green light in Norway, but Germany has rejected the product.

Where Are The Women? Nordic Biotech Searches For The ‘She-Suite’

 
• By 

For all its good intentions and lauded action toward gender equality, the biotech industry in Scandinavia and the Nordics has a female CEO rate hovering around 23%. While the number of women entering academia, innovative companies and laboratories is healthy, gender equality in the C-suite leaves a lot to be desired. 

Where Are The Women? Nordic Biotech Searches For The ‘She-Suite’

 
• By 

For all its good intentions and lauded action toward gender equality, the biotech industry in Scandinavia and the Nordics has a female CEO rate hovering around 23%. While the number of women entering academia, innovative companies and laboratories is healthy, gender equality in the C-suite leaves a lot to be desired. 

EU Designates First Czech Notified Body Under MDR

 

The latest notified body listing brings total number of EU designated Medical Device Regulation testing and certification organizations to 35.

Nordic Countries To Agree Closer Collaboration On Joint Price Negotiation And Procurement

 

Five Nordic countries are agreeing a common strategy for closer collaboration on access to hospital drugs.

EU Business News: Orkla Acquires Healthspan, Bayer Invests Locally, Ipsen Targets Baltics

 
• By 

A round-up of the latest European consumer health business news: Norway's Orkla strengthens its supplements offering with acquisition of UK's Healthspan; Bayer makes investment commitment to German Consumer Health operation; and Ipsen strikes a deal to promote brands in the Baltics.

Two MDR-Designated European Notified Bodies Become One

 

Norwegian notified body DNV acquires German competitor in move intended to address the peak in Medical Device Regulation certification demands.

Global Pharma Guidance Tracker – November 2021

 
• By 

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

ADVERTISEMENT